References | Country | Conditions | Sample size | Genotyping method | Polymorphism | NOS | |
---|---|---|---|---|---|---|---|
Case | Control | ||||||
Annunen [18] | Finland | IVDD | 314 | 202 | CSGE, sequencing | Trp2 | 8 |
Paassilta [19] | Finland | LDD | 171 | 321 | CSGE, sequencing | Trp3 | 7 |
Noponen-Hietala [46] | Finland | LDD | 29 | 56 | CSGE, sequencing | Trp2, Trp3 | 7 |
Pluijm [15] | Netherland | IVDD | 118 | 375 | PCR–RFLP | Sp1 | 8 |
Kales [44] | Greece | IVDD | 105 | 102 | PCR-pyrosequencing | Trp2, Trp3 | 8 |
Matsui [17] | America | IVDD | 97 | 10 | Sequencing | Trp2, Trp3 | 7 |
Tilkeridis [43] | Greece | LDD | 24 | 12 | Sequencing | Sp1 | 7 |
Jim [41] | China | IVDD | 514 | 290 | CSGE, sequencing | Trp2, Trp3 | 8 |
Solovieva [42] | Finland | LDD | 77 | 77 | CSGE, sequencing | Trp2, Trp3 | 8 |
Seki [40] | Japan | LDD | 470 | 658 | Sequencing, TaqMan | Trp2 | 8 |
Mio [22] | Japan | LDD | 881 | 841 | TaqMan | C4603T | 8 |
Song [38] | China | IVDD | 125 | 125 | SNPstream | Trp2 | 7 |
Hyun [37] | Korea | LDD | 205 | 101 | Sequencing | Trp2 | 7 |
Zhu [36] | America | IVDD | 25 | 7 | NR | Trp2, Trp3 | 7 |
Eskola [39] | Denmark | LDD | 66 | 154 | SNaPshot | Trp3 | 8 |
Kelempisioti [35] | Finland | IVDD | 150 | 246 | SNaPshot | Trp2, Trp3 | 8 |
Lim [45] | Singapore | LDD | 34 | 20 | Sequencing, TaqMan | Trp2, Trp3 | 7 |
Koyama [34] | Japan | IVDD | 44 | 55 | TaqMan | C4603T | 8 |
Omair [33] | Norway | LDD | 146 | 188 | MassARRAY | Trp3, C4603T | 8 |
Rathod [32] | India | IVDD | 100 | 100 | Real-time PCR | Trp2, Trp3 | 7 |
Lin [14] | China | IVDD | 375 | 118 | PCR–RFLP | Sp1 | 8 |
Anjankar [26] | India | IVDD | 50 | 50 | PCR | Sp1 | 8 |
Bagheri [25] | Iran | IVDD | 108 | 57 | Tetraplex PCR | Trp2, Trp3 | 7 |
Liu [21] | China | LDD | 657 | 532 | TaqMan | C4603T | 8 |
Koyama [24] | Japan | IVDD | 101 | 114 | TaqMan | C4603T | 8 |
Hanaei [23] | Iran | IVDD | 96 | 94 | TaqMan | Trp2 | 7 |